glp-1 agonists medications Examples: Which One Wins? America's Poison Centers - GLP-1
Description
In 2017, GIP(3-30)NH 2 was confirmed to be highly selective for the human GIP receptor without any agonistic properties
Although rare, serious side effects have been noted, with gallbladder disease and pancreatitis among the most concerning
10.1016/j.cell.2016.09.014
Dose can be increased in 2.5 mg increments every four weeks to a maximum of 15 mg weekly
Gliflozins in the management of cardiovascular disease
Six studies emphasized glycemic control, measuring hemoglobin A1c and glucose tolerance, crucial for reducing pregnancy complications such as fetal macrosomia and neonatal hypoglycemia
